Elkord E - Search Results

1

Effect of Boswellic acids on T cell proliferation and activation.

Meyiah A, Shawkat MY, Ur Rehman N, Al-Harrasi A, Elkord E. Meyiah A, et al. Among authors: elkord e. Int Immunopharmacol. 2023 Sep;122:110668. doi: 10.1016/j.intimp.2023.110668. Epub 2023 Jul 22. Int Immunopharmacol. 2023. PMID: 37487264

2

Structure-based small inhibitors search combined with molecular dynamics driven energies for human programmed cell death-1 (PD-1) protein.

Waqas M, Halim SA, Alsalman A, Khan A, Elkord E, Al-Harrasi A. Waqas M, et al. Among authors: elkord e. J Biomol Struct Dyn. 2023;41(24):14771-14785. doi: 10.1080/07391102.2023.2188958. Epub 2023 Mar 16. J Biomol Struct Dyn. 2023. PMID: 36927289

3

Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers.

Meyiah A, Alahdal M, Elkord E. Meyiah A, et al. Among authors: elkord e. iScience. 2023 Mar 4;26(4):106333. doi: 10.1016/j.isci.2023.106333. eCollection 2023 Apr 21. iScience. 2023. PMID: 36968082 Free PMC article. Review.

4

Corrigendum to "Effect of Boswellic acids on T cell proliferation and activation" [Int. Immunopharmacol. 122 (2023) 110668].

Meyiah A, Shawkat MY, Rehman NU, Al-Harrasi A, Elkord E. Meyiah A, et al. Among authors: elkord e. Int Immunopharmacol. 2024 Dec 28:113950. doi: 10.1016/j.intimp.2024.113950. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39734112 No abstract available.

5

The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer.

Mahmoodi Chalbatani G, Gharagouzloo E, Malekraeisi MA, Azizi P, Ebrahimi A, Hamblin MR, Mahmoodzadeh H, Elkord E, Miri SR, Sanati MH, Panahi B. Mahmoodi Chalbatani G, et al. Among authors: elkord e. Sci Rep. 2023 Nov 9;13(1):19454. doi: 10.1038/s41598-023-46620-z. Sci Rep. 2023. PMID: 37945594 Free PMC article.

6

Editorial: Novel biomarkers in tumor immunity and immunotherapy.

Matsutani T, Akbay E, Elkord E. Matsutani T, et al. Among authors: elkord e. Front Immunol. 2024 Apr 8;15:1405082. doi: 10.3389/fimmu.2024.1405082. eCollection 2024. Front Immunol. 2024. PMID: 38650943 Free PMC article. No abstract available.

7

Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?

Cui H, Elkord E. Cui H, et al. Among authors: elkord e. Vaccines (Basel). 2024 Nov 22;12(12):1306. doi: 10.3390/vaccines12121306. Vaccines (Basel). 2024. PMID: 39771968 Free article.

8

Effects of 1H-1,2,3-Triazole Derivatives of 3-O-Acetyl-11-Keto-Beta-Boswellic Acid from Boswellia sacra Resin on T-Cell Proliferation and Activation.

Meyiah A, Avula SK, Al-Harrasi A, Elkord E. Meyiah A, et al. Among authors: elkord e. Pharmaceuticals (Basel). 2024 Dec 8;17(12):1650. doi: 10.3390/ph17121650. Pharmaceuticals (Basel). 2024. PMID: 39770493 Free article.

9

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials.

Ren K, Hamdy H, Meyiah A, Elkord E. Ren K, et al. Among authors: elkord e. Front Immunol. 2024 Nov 26;15:1501613. doi: 10.3389/fimmu.2024.1501613. eCollection 2024. Front Immunol. 2024. PMID: 39660130 Free PMC article. Review.

10

What is the relevance of FoxP3 in the tumor microenvironment and cancer outcomes?

Meyiah A, Elkord E. Meyiah A, et al. Among authors: elkord e. Expert Rev Clin Immunol. 2024 Aug;20(8):803-809. doi: 10.1080/1744666X.2024.2334258. Epub 2024 Mar 25. Expert Rev Clin Immunol. 2024. PMID: 38512803 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters